BB Biotech AG : Publication pursuant to §26a WpHG (the German Securities Trading Act) with the aim of pan-European distribution
(Thomson Reuters ONE) -
BB Biotech AG /
BB Biotech AG : Publication pursuant to §26a WpHG (the German Securities Trading
Act) with the aim of pan-European distribution
. Processed and transmitted by Thomson Reuters ONE.
The issuer is solely responsible for the content of this announcement.
Pursuant to article 26a WpHG, BB Biotech AG, Vordergasse 3, 8200 Schaffhausen,
Switzerland, hereby announces that the total voting rights at the end of June
2013 amount to 11 850 000.
The new number of voting rights is effective as of June 17, 2013.
For further information please contact:
Bellevue Asset Management AG, Seestrasse 16, 8700 Küsnacht / Zurich
Thomas Egger, Tel. +41 44 267 67 00.
Release (PDF):
http://hugin.info/136834/R/1712777/568404.pdf
This announcement is distributed by Thomson Reuters on behalf of
Thomson Reuters clients. The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and
other applicable laws; and
(ii) they are solely responsible for the content, accuracy and
originality of the information contained therein.
Source: BB Biotech AG via Thomson Reuters ONE
[HUG#1712777]
Unternehmensinformation / Kurzprofil:
Datum: 28.06.2013 - 17:46 Uhr
Sprache: Deutsch
News-ID 274424
Anzahl Zeichen: 1393
contact information:
Town:
Schaffhausen
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 225 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"BB Biotech AG : Publication pursuant to §26a WpHG (the German Securities Trading Act) with the aim of pan-European distribution"
steht unter der journalistisch-redaktionellen Verantwortung von
BB Biotech AG (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
